Here are some of the developments in antitrust news this past week that we found interesting and are following.
U.S. Senate passes bill to raise fees on biggest mergers. The U.S. Senate passed a bill on Tuesday that would increase fees that companies planning the biggest mergers pay to government antitrust agencies and give those agencies bigger budgets. The bill - co-sponsored by Democrat Amy Klobuchar, the top...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
Facebook's Marketplace in EU and UK antitrust crosshairs. Europe and Britain launched formal antitrust investigations into Facebook on Friday to determine if the world's largest social network was using customer data to unfairly compete with advertisers, in a new assault on its business model. The...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
Bipartisan U.S. bill to raise merger fees for big deals passes Senate panel. A bill to increase the fees that companies planning the biggest mergers pay to government antitrust agencies and to give those agencies bigger budgets passed the Senate Judiciary Committee on Thursday on a voice vote. The bill -...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
EU hopes new foreign buyer rules agreed within next year. The European Union’s antitrust chief is hopeful draft rules intended to curb state-backed foreign buyers will be agreed within the next year, she said on Thursday. The rules aim to prevent companies that benefit from distorting foreign subsidies...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
U.S. lawmakers introduce eight antitrust bills aimed at drug prices. U.S. lawmakers from both parties and both houses of Congress have introduced eight antitrust bills aimed at tackling the problem of high and rising drug prices, including bills to stop brand name drug companies from paying generic firms...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
What U.S. Supreme Court took away from the FTC, Congress can give back. The U.S. Supreme Court, by a 9-0 vote, on Thursday gutted the Federal Trade Commission's ability to force scam artists and companies that acted deceptively to return ill-gotten gains, ruling in favor of a criminally convicted payday...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
4th Circuit revives antitrust claims against Actelion over Tracleer pricing. The 4th U.S. Circuit Court of Appeals on Tuesday revived a proposed class action against Janssen’s Actelion Pharmaceuticals Ltd accusing the company of extending its patent monopoly on its pulmonary artery hypertension drug...